Skip to main content
. 2019 Jun 1;14:456–466. doi: 10.1515/med-2019-0049

Figure 6.

Figure 6

miR-107 significantly decreases breast cancer cell viability after treated with PTX. The cell viability of breast cancer cells in different groups was measured by the MTT assay. **P<0.01, PTX vs control; PTX + miR-107 vs PTX + NC; PTX + TPD52 + miR-107 vs PTX +miR-107. Control, un-treated cells; PTX, cells were exposed to PTX with the concentration of 0.1μg/ml; NC, miR-107 mimics negative control-transfected cells; miR-107, miR-107 mimics-transfected cells; TPD52, tumor protein D52, cells transfected with pcDNA3.1-TPD52.